GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$91.34 USD
+0.52 (0.57%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $91.35 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$91.34 USD
+0.52 (0.57%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $91.35 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Zacks News
Stock Market News for Feb 7, 2024
by Zacks Equity Research
U.S. stock markets higher on Tuesday after a sharp fall on Monday.
GE HealthCare (GEHC) Q4 Earnings Beat, Volume & Price Improve
by Zacks Equity Research
GE HealthCare's (GEHC) fourth-quarter results benefit from continued demand for imaging, patient care and pharmaceutical diagnostic solutions. Sales gain from improved pricing.
GE HealthCare (GEHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
GE HealthCare Technologies (GEHC) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
GE HealthCare (GEHC) delivered earnings and revenue surprises of 10.28% and 2.21%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
GE HealthCare (GEHC) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
GE HealthCare (GEHC) is expected to report strong organic revenue growth, banking on balanced segmental performance, driven by consistent NPIs and growing customer demand.
GE Healthcare (GEHC) Buys MIM Software to Boost Imaging Tools
by Zacks Equity Research
GE Healthcare (GEHC) is likely to enhance medical imaging capabilities and boost powerful AI solutions with the acquisition of MIM Software. Financial details are kept under cover.
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE
The Zacks Analyst Blog Highlights DaVita, GE HealthCare Technologies and Hologic
by Zacks Equity Research
DaVita, GE HealthCare Technologies and Hologic are part of the Zacks top Analyst Blog.
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2024
by Debanjana Dey
Here are some dirt-cheap MedTech value stocks - DVA, GEHC, HOLX - which are expected to provide long-term gains.
3 MedTech Stocks With Potential to Benefit From AI Boom in 2024
by Indrajit Bandyopadhyay
Investors looking to tap the budding prospects in the lucrative AI market in 2024 can count on Medtronic (MDT), GE HealthCare Technologies (GEHC) and Hologic (HOLX).
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
GE HealthCare Technologies (GEHC) Crossed Above the 200-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
Masimo's (MASI) Latest Tie-Up to Boost Patient Monitoring
by Zacks Equity Research
Masimo's (MASI) latest joint effort is likely to enable real-time continuous monitoring with a tailored view of the patient's vitals while keeping them mobile during critical recovery periods.
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE
GE HealthCare (GEHC) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
GE HealthCare (GEHC) is expected to report strong organic revenue growth, banking on balanced segmental performance driven by consistent NPIs and growing customer demand.
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
Stock Market News for Sep 26, 2023
by Zacks Equity Research
U.S. stock markets closed higher on Monday to start the last week of a highly volatile September.
GEHC or PRVA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GEHC vs. PRVA: Which Stock Is the Better Value Option?
GEHC or PRVA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GEHC vs. PRVA: Which Stock Is the Better Value Option?
GEHC or PRVA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GEHC vs. PRVA: Which Stock Is the Better Value Option?
GE HealthCare (GEHC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
GE HealthCare (GEHC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
GEHC vs. PRVA: Which Stock Is the Better Value Option?
by Zacks Equity Research
GEHC vs. PRVA: Which Stock Is the Better Value Option?
GE HealthCare (GEHC) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
GE HealthCare's (GEHC) Imaging revenue growth in Q2 is expected to have been led by Magnetic Resonance as well as its molecular imaging entity.
The Zacks Analyst Blog Highlights InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare
by Zacks Equity Research
InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare are included in this Analyst Blog.
Solid Earnings Fuel Potential Bull Market in Medical Devices
by Indrajit Bandyopadhyay
CNBC's Jim Cramer predicts a booming bull market for medical devices, with positive earnings reports across the space. INMD, JNJ, ISRG and GEHC can emerge as potential winners.